Search research articles
Contact Us
Filters
Showing results (241-250 of 332) with videos related to
Page
of 34
Sort By:
The Journal of Urology
|
November 25, 2015
Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?
Daan J Reesink, Elisabeth E Fransen van de Putte, Erik Vegt, et al.
European Urology
|
October 17, 2022
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel
Umberto Capitanio, Jens Bedke, Laurence Albiges, et al.
BMJ Open
|
June 14, 2019
Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing <b>NE</b>phron <b>S</b>paring <b>T</b>reatment (NEST) for small renal masses
Joana B Neves, David Cullen, Lee Grant, et al.
EJNMMI Research
|
December 5, 2018
An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors
Teele Kuusk, Maarten L Donswijk, Renato A Valdés Olmos, et al.
European Urology
|
December 11, 2017
Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer
Thomas Powles, Laurence Albiges, Michael Staehler, et al.
Trials
|
March 21, 2026
PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trial
Diana Johnson, Ruth Thomas, Seonaidh Cotton, et al.
European Urology Oncology
|
September 26, 2024
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions
Laura Marandino, Riccardo Campi, Daniele Amparore, et al.
Applied Health Economics and Health Policy
|
May 19, 2021
How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England
Caroline S Clarke, Cecilia Vindrola-Padros, Claire Levermore, et al.
Applied Health Economics and Health Policy
|
July 22, 2022
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis
Caroline S Clarke, Mariya Melnychuk, Angus I G Ramsay, et al.
Journal of Health Services Research & Policy
|
April 26, 2022
Loss associated with subtractive health service change: The case of specialist cancer centralization in England
Georgia B Black, Victoria J Wood, Angus I G Ramsay, et al.
Page
of 34
Search research articles
Search
Showing results (241-250 of 332) with videos related to
Sort By:
Page
of 34
The Journal of Urology
|
November 25, 2015
Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?
Daan J Reesink, Elisabeth E Fransen van de Putte, Erik Vegt, et al.
European Urology
|
October 17, 2022
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel
Umberto Capitanio, Jens Bedke, Laurence Albiges, et al.
BMJ Open
|
June 14, 2019
Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing <b>NE</b>phron <b>S</b>paring <b>T</b>reatment (NEST) for small renal masses
Joana B Neves, David Cullen, Lee Grant, et al.
EJNMMI Research
|
December 5, 2018
An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors
Teele Kuusk, Maarten L Donswijk, Renato A Valdés Olmos, et al.
European Urology
|
December 11, 2017
Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer
Thomas Powles, Laurence Albiges, Michael Staehler, et al.
Trials
|
March 21, 2026
PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trial
Diana Johnson, Ruth Thomas, Seonaidh Cotton, et al.
European Urology Oncology
|
September 26, 2024
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions
Laura Marandino, Riccardo Campi, Daniele Amparore, et al.
Applied Health Economics and Health Policy
|
May 19, 2021
How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England
Caroline S Clarke, Cecilia Vindrola-Padros, Claire Levermore, et al.
Applied Health Economics and Health Policy
|
July 22, 2022
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis
Caroline S Clarke, Mariya Melnychuk, Angus I G Ramsay, et al.
Journal of Health Services Research & Policy
|
April 26, 2022
Loss associated with subtractive health service change: The case of specialist cancer centralization in England
Georgia B Black, Victoria J Wood, Angus I G Ramsay, et al.
Page
of 34